• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Correction: Vidofludimus inhibits porcine reproductive and respiratory syndrome virus infection by targeting dihydroorotate dehydrogenase.更正：维多福啶通过靶向二氢乳清酸脱氢酶抑制猪繁殖与呼吸综合征病毒感染。
Vet Res. 2024 Dec 27;55(1):173. doi: 10.1186/s13567-024-01447-y.
2
Vidofludimus inhibits porcine reproductive and respiratory syndrome virus infection by targeting dihydroorotate dehydrogenase.维地福卢米司抑制猪繁殖与呼吸综合征病毒感染的作用机制是靶向二氢乳清酸脱氢酶。
Vet Res. 2023 Dec 20;54(1):124. doi: 10.1186/s13567-023-01251-0.
3
Identification of dihydroorotate dehydrogenase inhibitor, vidofludimus, as a potent and novel inhibitor for influenza virus.鉴定二氢乳清酸脱氢酶抑制剂维地福卢米司他是一种新型有效的流感病毒抑制剂。
J Med Virol. 2024 Jan;96(1):e29372. doi: 10.1002/jmv.29372.
4
A double-blind, randomized, placebo-controlled phase 2 trial evaluating the selective dihydroorotate dehydrogenase inhibitor vidofludimus calcium in relapsing-remitting multiple sclerosis.一项评估选择性二氢乳清酸脱氢酶抑制剂维地福卢米昔钙在复发缓解型多发性硬化症中的双盲、随机、安慰剂对照 2 期试验。
Ann Clin Transl Neurol. 2022 Jul;9(7):977-987. doi: 10.1002/acn3.51574. Epub 2022 Jun 14.
5
Safety and Efficacy of Vidofludimus Calcium in Patients Hospitalized with COVID-19: A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial.维达氟啶钙治疗 COVID-19 住院患者的安全性和有效性：一项双盲、随机、安慰剂对照的 2 期试验。
Infect Dis Ther. 2022 Dec;11(6):2159-2176. doi: 10.1007/s40121-022-00690-0. Epub 2022 Oct 15.
6
Drug repurposing screen identifies vidofludimus calcium and pyrazofurin as novel chemical entities for the development of hepatitis E interventions.药物重定位筛选发现维地弗鲁米钙和吡嗪弗林作为开发戊型肝炎干预措施的新型化学实体。
Virol Sin. 2024 Feb;39(1):123-133. doi: 10.1016/j.virs.2023.11.006. Epub 2023 Nov 19.
7
Repositioning an Immunomodulatory Drug Vidofludimus as a Farnesoid X Receptor Modulator With Therapeutic Effects on NAFLD.将免疫调节药物维多氟啶重新定位为法尼酯X受体调节剂，对非酒精性脂肪性肝病具有治疗作用。
Front Pharmacol. 2020 May 14;11:590. doi: 10.3389/fphar.2020.00590. eCollection 2020.
8
Vidofludimus calcium, a next generation DHODH inhibitor for the Treatment of relapsing-remitting multiple sclerosis.维地福卢米单抗钙，一种用于治疗复发缓解型多发性硬化症的新一代二氢乳清酸脱氢酶抑制剂。
Mult Scler Relat Disord. 2020 Aug;43:102129. doi: 10.1016/j.msard.2020.102129. Epub 2020 May 6.
9
The Selective Oral Immunomodulator Vidofludimus in Patients with Active Rheumatoid Arthritis: Safety Results from the COMPONENT Study.选择性口服免疫调节剂 Vidofludimus 治疗活动期类风湿关节炎患者：COMPONENT 研究的安全性结果。
Drugs R D. 2019 Dec;19(4):351-366. doi: 10.1007/s40268-019-00286-z.
10
Synthesis and Characterization of DHODH Inhibitors Based on the Vidofludimus Scaffold with Pronounced Anti-SARS-CoV-2 Activity.基于 Vidofludimus 支架的 DHODH 抑制剂的合成与表征，具有显著抗 SARS-CoV-2 活性。
ChemMedChem. 2024 Oct 1;19(19):e202400292. doi: 10.1002/cmdc.202400292. Epub 2024 Aug 6.

本文引用的文献

1
Vidofludimus inhibits porcine reproductive and respiratory syndrome virus infection by targeting dihydroorotate dehydrogenase.维地福卢米司抑制猪繁殖与呼吸综合征病毒感染的作用机制是靶向二氢乳清酸脱氢酶。
Vet Res. 2023 Dec 20;54(1):124. doi: 10.1186/s13567-023-01251-0.

Correction: Vidofludimus inhibits porcine reproductive and respiratory syndrome virus infection by targeting dihydroorotate dehydrogenase.

作者信息

Yang Yuanqi, Gao Yanni, Zhang Lujie, Liu Xing, Sun Yangyang, Bai Juan, Jiang Ping

机构信息

Key Laboratory of Animal Diseases Diagnostic and Immunology, Ministry of Agriculture, MOE International Joint Collaborative Research Laboratory for Animal Health & Food Safety, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing, 210095, China.

Jiangsu Co-Innovation Center for the Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou University, Yangzhou, 225009, China.

出版信息

Vet Res. 2024 Dec 27;55(1):173. doi: 10.1186/s13567-024-01447-y.

DOI:10.1186/s13567-024-01447-y
PMID:39731128
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11681666/
Abstract
摘要